Thus, inhibition of EZH2 can reduce the survival and invasion of clear cell renal cell carcinoma (ccRCC) cells and the growth of ccRCC in xenografted mice (Sun et al., 2018). The gene discussed is EZH2; the disease is nonpapillary renal cell carcinoma.